Literature DB >> 30742976

Cost-effectiveness of microdiscectomy versus endoscopic discectomy for lumbar disc herniation.

Kyung-Chul Choi1, Hyeong-Ki Shim1, Jin-Sung Kim2, Kyung Han Cha1, Dong Chan Lee1, Ea Ran Kim1, Mee Jung Kim1, Choon-Keun Park3.   

Abstract

BACKGROUND CONTEXT: Microdiscectomy is a standard technique for the surgical treatment of lumbar disc herniation (LDH). Endoscopic discectomy (ED) is another surgical option that has become popular owing to reports of shorter hospitalization and earlier return to work. No study has evaluated health care costs associated with lumbar discectomy techniques and compared cost-effectiveness.
PURPOSE: To assess the cost-effectiveness of four surgical techniques for LDH: microdiscectomy (MD), transforaminal endoscopic lumbar discectomy (TELD), interlaminar endoscopic lumbar discectomy (IELD), and unilateral biportal endoscopic discectomy (UBED). STUDY DESIGN AND
SETTING: Retrospective analysis. PATIENT SAMPLE: Patients who underwent either MD or ED for primary LDH with 1-year follow-up between the ages of 20 and 60 years old. OUTCOME MEASURES: Incremental cost-effectiveness ratio (ICER).
METHODS: Five hundred sixty-five patients aged 20-60 years who underwent treatment using one of the four surgical techniques with at least 1-year follow-up were reviewed. Health care costs were defined as the sum of direct and indirect costs. The former included the covered and uncovered costs of the National Health Insurance from operation to 1-year follow-up; indirect costs included costs incurred by work loss. Direct and indirect costs were evaluated separately. ICER was determined using cost/quality-adjusted life year (QALY). Health care costs and ICER were compared statistically among the four surgical groups. Cost-effectiveness was compared statistically between MD and ED.
RESULTS: One hundred fifty-seven patients who underwent TELD, 132 for IELD, 140 for UBED, and 136 for MD were enrolled. The direct costs of TELD, IELD, UBED, and MD were $3,452.2±1,211.5, $3,907.3±895.3, $4,049.2±1,134.6, and $4,302.1±1,028.9, respectively (p<.01). The indirect costs of TELD, IELD, UBED, and MD were $574.5±495.9, $587.8±488.3, $647.4±455.6, and $759.7±491.7, respectively (p<.01). The 1-year QALY gains were 0.208 for TELD, 0.211 for IELD, 0.194 for UBED, and 0.186 for MD. ICER (costs/QALY) was the highest for MD ($34,840.4±25,477.9, p<.01). Compared with MD, ED saved an additional net of $8,064 per QALY (p<.01). There was no significant difference in the ICERs among the three endoscopic techniques.
CONCLUSIONS: ED was more cost-effective compared with MD at 1-year follow up.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cost-effectiveness; Endoscopic discectomy; Incremental cost-effectiveness ratio; Microdiscectomy; Quality-adjusted life year

Mesh:

Year:  2019        PMID: 30742976     DOI: 10.1016/j.spinee.2019.02.003

Source DB:  PubMed          Journal:  Spine J        ISSN: 1529-9430            Impact factor:   4.166


  17 in total

1.  Worldwide research productivity in the field of full-endoscopic spine surgery: a bibliometric study.

Authors:  Guang-Xun Lin; Vit Kotheeranurak; Akaworn Mahatthanatrakul; Sebastian Ruetten; Anthony Yeung; Sang-Ho Lee; Yong Ahn; Hyeun-Sung Kim; Christoph Hofstetter; Jun-Ho Lee; Kyung-Chul Choi; Kai-Uwe Lewandrowski; Jin-Sung Kim
Journal:  Eur Spine J       Date:  2019-10-23       Impact factor: 3.134

2.  Full-endoscopic versus microscopic unilateral laminotomy for bilateral decompression of lumbar spinal stenosis at L4-L5: comparative study.

Authors:  Kuo-Tai Chen; Kyung-Chul Choi; Hyeong-Ki Shim; Dong-Chan Lee; Jin-Sung Kim
Journal:  Int Orthop       Date:  2022-08-19       Impact factor: 3.479

3.  Rationale and Advantages of Endoscopic Spine Surgery.

Authors:  Jae-Won Jang; Dong-Geun Lee; Choon-Keun Park
Journal:  Int J Spine Surg       Date:  2021-12

4.  Percutaneous Endoscopic Lumbar Discectomy Versus Microdiscectomy for the Treatment of Lumbar Disc Herniation: Pain, Disability, and Complication Rate-A Randomized Clinical Trial.

Authors:  Guilherme Meyer; Ivan Dias DA Rocha; Alexandre Fogaça Cristante; Raphael Martus Marcon; Thiago Pereira Coutinho; Alessandro Gonzalez Torelli; Pedro Araujo Petersen; Olavo Biraghi Letaif; Tarcísio Eloy Pessoa DE Barros Filho
Journal:  Int J Spine Surg       Date:  2020-02-29

5.  Estimation and influence of blood loss under endoscope for percutaneous endoscopic lumbar discectomy (PELD): a clinical observational study combined with in vitro experiment.

Authors:  Dong Dong Sun; Dan Lv; Wei Zhou Wu; He Fei Ren; Bu He Bao; Qun Liu; Ming Lin Sun
Journal:  J Orthop Surg Res       Date:  2020-07-25       Impact factor: 2.359

6.  Evaluation of efficacy and safety of percutaneous transforaminal endoscopic surgery (PTES) for surgical treatment of calcified lumbar disc herniation: a retrospective cohort study of 101 patients.

Authors:  Hao Wang; Tianyao Zhou; Yutong Gu; Zuoqin Yan
Journal:  BMC Musculoskelet Disord       Date:  2021-01-12       Impact factor: 2.362

7.  Cost effectiveness of outpatient lumbar discectomy.

Authors:  Bernardo Sousa-Pinto; Nuno Neves; Daniela Linhares; João A Fonseca; Manuel Ribeiro da Silva; Filipe Conceição; António Sousa
Journal:  Cost Eff Resour Alloc       Date:  2021-03-26

8.  Learning curve of percutaneous endoscopic transforaminal lumbar discectomy by a single surgeon.

Authors:  Seong Son; Yong Ahn; Sang Gu Lee; Woo Kyung Kim; Byung Rhae Yoo; Jong Myung Jung; Joon Cho
Journal:  Medicine (Baltimore)       Date:  2021-01-29       Impact factor: 1.817

9.  Learning curve of percutaneous endoscopic interlaminar lumbar discectomy versus open lumbar microdiscectomy at the L5-S1 level.

Authors:  Seong Son; Yong Ahn; Sang Gu Lee; Woo Kyung Kim
Journal:  PLoS One       Date:  2020-07-30       Impact factor: 3.240

10.  Is Less Really More? Economic Evaluation of Minimally Invasive Surgery.

Authors:  Andrew S Chung; Alexander Ballatori; Brandon Ortega; Elliot Min; Blake Formanek; John Liu; Patrick Hsieh; Raymond Hah; Jeffrey C Wang; Zorica Buser
Journal:  Global Spine J       Date:  2020-09-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.